| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.5M | +169.4% |
| SG&A Expense | $8.8M | -5.8% |
| Operating Income | -$15.7M | +62.4% |
| Interest Expense | $13K | -99.5% |
| Income Tax | $0 | — |
| Net Income | -$14.3M | +46.4% |
| EPS (Basic) | -$16.53 | -478.0% |
| EPS (Diluted) | -$16.53 | -387.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | +18.0% |
| Current Assets | $14.7M | +19.1% |
| Total Assets | $15.8M | +26.0% |
| Current Liabilities | $3.0M | +20.7% |
| Total Liabilities | $3.3M | -36.2% |
| Stockholders' Equity | $12.5M | +69.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.4M | +9.6% |
| Capital Expenditures | $10K | — |
| Investing Cash Flow | -$10K | +81.5% |
| Financing Cash Flow | $15.3M | -38.0% |
| Free Cash Flow | -$13.4M | +9.5% |